829
Participants
Start Date
December 31, 2002
Primary Completion Date
January 31, 2004
Study Completion Date
January 31, 2004
Ramelteon
Ramelteon 4 mg, tablets, orally, once daily for up to 5 weeks.
Ramelteon
Ramelteon 8 mg, tablets, orally, once daily for up to 5 weeks.
Placebo
Ramelteon placebo-matching, tablets, orally, each night for up to 35 consecutive days.
Columbiana
Mobile
Muscle Shoals
Tallahassee
Phoenix
Scottsdale
Tempe
Hot Springs
Little Rock
Anaheim
Encinitas
Irvine
La Jolla
La Mesa
Los Angeles
Murrieta
Northridge
Oakland
Redlands
Riverside
Rosemead
San Diego
Spring Valley
Vista
Colorado Springs
Denver
Clearwater
DeLand
Hollywood
Jacksonville
Kissimmee
Longwood
Pembroke Pines
Pinellas Park
Safety Harbor
St. Petersburg
Tampa
Vero Beach
West Palm Beach
Winter Park
Atlanta
Blairsville
Macon
Chciago
Northfield
Evansville
Shawnee Mission
Wichita
Louisville
Murray
New Orleans
Bethesda
Belmont
Brockton
Newton
Detroit
Hattiesburg
Kansas City
St Louis
Lincoln
Las Vegas
Brick
Edison
Toms River
Albuquerque
Great Neck
Manlius
Mineola
Williamsville
Cary
Greensboro
Hickory
Raleigh
Salisbury
Winston-Salem
Beachwood
Canfield
Cincinnati
Toledo
Oklahoma City
Tulsa
Eugene
Portland
Jenkintown
Reading
Scotland
Warwick
Anderson
Greer
Mt. Pleasant
Fayetteville
Johnson City
Dallas
Fort Worth
Houston
San Antonio
Salt Lake City
Norfolk
Bellevue
Gig Harbor
Madison
New Berlin
Calgary
Edmonton
Medicine Hat
North Vancouver
Winnipeg
St. John's
Corunna
London
North Bay
Sarnia
Toronto
Parkdale
Montreal
Lead Sponsor
Takeda
INDUSTRY